Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 20; 27(27):4462-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Benzenesulfonates
Carcinoma, Renal Cell
Female
Humans
Imidazoles
Indazoles
Kidney Neoplasms
Male
Middle Aged
Niacinamide
Phenylurea Compounds
Pyridines
authors with profiles
Walter M. Stadler